Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eosinophilic Pulmonary Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06026202
What this trial is testing

Non-Eosinophilic Biological Effects of IL-5

Who this might be right for
Asthma
Imperial College London 5
Not applicableStudy completedNCT03833141
What this trial is testing

Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 170
Testing effectiveness (Phase 2)Looking for participantsNCT07323654
What this trial is testing

KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Kymera Therapeutics, Inc. 264
Not applicableUnknownNCT02555345
What this trial is testing

Gene Expression Profile and Inflammation Profile of Classic Asthma, Cough Variant Asthma and Eosinophilic Bronchitis

Who this might be right for
Asthmatic Bronchitis
State Key Laboratory of Respiratory Disease 250
Testing effectiveness (Phase 2)Study completedNCT00292877
What this trial is testing

The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)

Who this might be right for
Asthma
St. Joseph's Healthcare Hamilton 20
Large-scale testing (Phase 3)Looking for participantsNCT07190222
What this trial is testing

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sanofi 942
Large-scale testing (Phase 3)Study completedNCT04719832
What this trial is testing

Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Who this might be right for
Asthma
GlaxoSmithKline 395
Post-approval studies (Phase 4)UnknownNCT05596721
What this trial is testing

Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma

Who this might be right for
AsthmaChest SyndromeAzithromycin+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 248
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableUnknownNCT04008017
What this trial is testing

Eosinophilic Cationic Protein as a Biomarker in Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Assiut University 64
Post-approval studies (Phase 4)Study completedNCT03610685
What this trial is testing

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

Who this might be right for
Asthma
NHS Greater Glasgow and Clyde 33
Not applicableEnded earlyNCT00509197
What this trial is testing

Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?

Who this might be right for
Asthma
Université de Montréal 12
Post-approval studies (Phase 4)Looking for participantsNCT04565483
What this trial is testing

Predictive Signature of Benralizumab Response

Who this might be right for
Asthma; EosinophilicSevere Asthma
Nantes University Hospital 220
Post-approval studies (Phase 4)Study completedNCT02654145
What this trial is testing

Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients

Who this might be right for
Asthma
GlaxoSmithKline 145
Large-scale testing (Phase 3)Looking for participantsNCT07444567
What this trial is testing

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

Who this might be right for
AsthmaEosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilic Syndrome (HES)
AstraZeneca 230
Testing effectiveness (Phase 2)Study completedNCT03299686
What this trial is testing

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 118
Not applicableUnknownNCT05241769
What this trial is testing

The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
University Hospital Birmingham 250
Not applicableLooking for participantsNCT01241305
What this trial is testing

One-Time DNA Study for Vasculitis

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)Giant Cell ArteritisGranulomatosis With Polyangiitis (Wegener's)+3 more
University of Pennsylvania 1,000
Not applicableStudy completedNCT03976310
What this trial is testing

CT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients

Who this might be right for
Asthma
University Hospital, Montpellier 59
Post-approval studies (Phase 4)Study completedNCT02169323
What this trial is testing

Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics

Who this might be right for
Asthma
Renaud Louis 43
Next Page